MCA logo



Bluebird Bio’s Lovo-Cel For Sickle Cell Disease Finally Under FDA Review

Sickle Cell
Bluebird Bio1 submits application to FDA for gene therapy lovo-cel for approval to treat people aged 12+ with sickle cell disease

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

health vietnam hospital
Weekly Asian Medical News Bulletin – 7 July 2023

Medical Channel Asia presents the weekly Asian medical news bulletin, bringing you essential healthcare news from across the region. This week’s Medical Health Bulletin will discuss preventive healthcare in Singapore, Tuberculosis in the Philippines and HFMD in Vietnam.

Read More »